These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1871934)

  • 21. [Intravesical instillations of BCG and bladder carcinoma in situ].
    Haab F; Dauge MC; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):988-94; discussion 992-3. PubMed ID: 8305942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICUD-EAU International Consultation on Bladder Cancer 2012: Urothelial carcinoma of the prostate.
    Palou J; Wood D; Bochner BH; van der Poel H; Al-Ahmadie HA; Yossepowitch O; Soloway MS; Jenkins LC;
    Eur Urol; 2013 Jan; 63(1):81-7. PubMed ID: 22938869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Instillation therapy in superficial urinary bladder cancer. Finnbladder Group.
    Jauhiainen KE; Alfthan OS
    Scand J Urol Nephrol Suppl; 1991; 138():179-85. PubMed ID: 1785001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of intravesical therapy for superficial bladder cancer.
    Lamm DL
    Urol Clin North Am; 1992 Aug; 19(3):573-80. PubMed ID: 1636241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of superficial bladder cancer.
    Grossman HB
    Compr Ther; 1995 May; 21(5):245-8. PubMed ID: 7621655
    [No Abstract]   [Full Text] [Related]  

  • 27. Pathologic and structural changes in the bladder after BCG intravesical therapy in men.
    Pagano F; Bassi P; Milani C; Dalla Palma P; Rebuffi AG; Poletti A; Parenti A
    Prog Clin Biol Res; 1989; 310():81-91. PubMed ID: 2771996
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder.
    Takenaka A; Yamada Y; Miyake H; Hara I; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):309-13. PubMed ID: 18380817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of carcinoma in situ of the urinary bladder with BCG].
    Schnyder von Wartensee M; Ackermann D; Studer UE; Zingg EJ
    Helv Chir Acta; 1989 Aug; 56(3):351-4. PubMed ID: 2807965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.
    Burger M; Oosterlinck W; Konety B; Chang S; Gudjonsson S; Pruthi R; Soloway M; Solsona E; Sved P; Babjuk M; Brausi MA; Cheng C; Comperat E; Dinney C; Otto W; Shah J; Thürof J; Witjes JA;
    Eur Urol; 2013 Jan; 63(1):36-44. PubMed ID: 22981672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Invasive bladder cancer with concomitant carcinoma in situ treated with chemoradiotherapy followed by BCG intravesical infusion therapy to preserve the bladder : report of three cases].
    Ohzeki T; Hashimoto K; Katoh Y; Iguchi M
    Hinyokika Kiyo; 2011 Oct; 57(10):581-4. PubMed ID: 22089159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J; Goldberg G
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of primary carcinoma in situ of the bladder].
    Mori Y; Shima H; Ihara H; Yabumoto H; Taguchi K; Koike H; Nojima M; Yamamoto H; Ikoma F
    Hinyokika Kiyo; 1996 Jan; 42(1):17-21. PubMed ID: 8686577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
    Okuno H; Shirahase T; Kihara Y; Arai Y
    Hinyokika Kiyo; 1989 Sep; 35(9):1503-7. PubMed ID: 2816616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transitional cell carcinoma in prostate after intravesical instillation of Bacillus Calmette-Guerin].
    Ito Y; Nishiyama H; Higashi S; Kinoshita H; Ito N; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2004 May; 50(5):335-8. PubMed ID: 15237488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravesical BCG therapy in patients with superficial bladder tumors.
    Steg A; Belas M; Leleu C; Boccon-Gibod L
    Prog Clin Biol Res; 1989; 310():153-60. PubMed ID: 2771990
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term effect of intravesical bacillus Calmette-Guérin (BCG) Tice strain on flat carcinoma in situ of the bladder.
    Reitsma DJ; Guinan P; Lamm DL; Khanna OP; Brosma SA; DeKernion JB; Williams RD; Sipmson G; Hanna MG
    Prog Clin Biol Res; 1989; 310():171-85. PubMed ID: 2672014
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?
    Lamm DL
    Cancer Surv; 1998; 31():99-108. PubMed ID: 15281319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.